News
-
-
-
COMMUNIQUÉ DE PRESSE
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
Wellgistics Health, Inc. and Kare PharmTech's subsidiary join forces to enhance pharmaceutical access and fulfillment for 200,000+ patients. The joint venture combines technology and operations, aiming for streamlined patient access and improved efficiency -
-
-
COMMUNIQUÉ DE PRESSE
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Wellgistics Health, Inc. announces non-binding Letter of Intent to acquire Neuritek Therapeutics, a neuroscience-focused research organization, enhancing its healthcare platform -
-
-
COMMUNIQUÉ DE PRESSE
Wellgistics Health Announces Launch of Diabetes Drug Brenzavvy(R) to Wellgistics Pharmacy Network
Wellgistics Health launches Brenzavvy to target the $16 billion SGLT-2 inhibitor market, focusing on patient education and reduced costs. Proprietary EinsteinRx AI platform supports broader market access and enhanced care experience for diabetics -
